"June 10, 2015 -- A new class of medications can lower "bad" LDL cholesterol to unheard-of levels, and it may be on the horizon.
The new class is called PCSK9 inhibitors. An FDA advisory panel on Tuesday recommended that the agency approve t"...
EPANOVA is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to EPANOVA or any of its components.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 5/20/2014
Additional Epanova Information
Report Problems to the Food and Drug Administration
Tips to keep it under control.